Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-07-14), the Trailing Annual Dividend Yield of We Can Medicines Co is 0.00%.
The historical rank and industry rank for We Can Medicines Co's Dividend Yield % or its related term are showing as below:
During the past 6 years, the highest Dividend Yield of We Can Medicines Co was 0.87%. The lowest was 0.00%. And the median was 0.73%.
ROCO:6929's Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.85 * Ranked among companies with meaningful Dividend Yield % only.
During the past 12 months, We Can Medicines Co's average Dividends Per Share Growth Rate was -100.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
We Can Medicines Co (ROCO:6929) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
We Can Medicines Co Dividend Yield % Related Terms
We Can Medicines Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6929 vs KHC, GIS: Dividend Yield % Comparison
For the Packaged Foods subindustry, We Can Medicines Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's Dividend Yield % falls into.
We Can Medicines Co (ROCO:6929) has a Dividend Yield % of 0.00% as of Jul. 14, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on We Can Medicines Co and its competitors. According to the industry distribution chart, We Can Medicines Co ranks #999999 out of 1175 companies in the Consumer Packaged Goods industry.
Is We Can Medicines Co's Dividend Yield % too high?
We Can Medicines Co's current Dividend Yield % is 0.00%. Based on the distribution chart, We Can Medicines Co ranks #999999 out of 1175 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's Dividend Yield % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #999999 out of 1175 companies for Dividend Yield %. This places We Can Medicines Co in the lower half of its industry. The industry median Dividend Yield % is 2.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Consumer Packaged Goods company?
The median Dividend Yield % among Consumer Packaged Goods companies is 2.85, based on 1,175 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median Dividend Yield % is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current Dividend Yield % is 0.00%. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
Dividend Yield %: 0.00%
GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
